ATE502030T1 - Imidazolderivate, verfahren zu deren herstellung und deren verwendung - Google Patents

Imidazolderivate, verfahren zu deren herstellung und deren verwendung

Info

Publication number
ATE502030T1
ATE502030T1 AT01982839T AT01982839T ATE502030T1 AT E502030 T1 ATE502030 T1 AT E502030T1 AT 01982839 T AT01982839 T AT 01982839T AT 01982839 T AT01982839 T AT 01982839T AT E502030 T1 ATE502030 T1 AT E502030T1
Authority
AT
Austria
Prior art keywords
ring
chem
production
alkyl group
membered
Prior art date
Application number
AT01982839T
Other languages
English (en)
Inventor
Akihiro Tasaka
Nobuyuki Matsunaga
Akio Ojida
Masami Kusaka
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE502030T1 publication Critical patent/ATE502030T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01982839T 2000-11-20 2001-11-19 Imidazolderivate, verfahren zu deren herstellung und deren verwendung ATE502030T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000353634 2000-11-20
JP2000382056 2000-12-15
PCT/JP2001/010079 WO2002040470A1 (en) 2000-11-20 2001-11-19 Imidazole derivatives, process for their preparation and their use

Publications (1)

Publication Number Publication Date
ATE502030T1 true ATE502030T1 (de) 2011-04-15

Family

ID=26604319

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01982839T ATE502030T1 (de) 2000-11-20 2001-11-19 Imidazolderivate, verfahren zu deren herstellung und deren verwendung

Country Status (7)

Country Link
US (1) US6960586B2 (de)
EP (1) EP1344777B1 (de)
AT (1) ATE502030T1 (de)
AU (1) AU2002214320A1 (de)
CA (1) CA2429437A1 (de)
DE (1) DE60144246D1 (de)
WO (1) WO2002040470A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0314872A (pt) * 2002-10-18 2005-08-02 Pfizer Prod Inc Ligandos do receptor canabinóide e usos dos mesmos
US20060100188A1 (en) * 2004-11-09 2006-05-11 Chen Zong Treatment methods
US20070111979A1 (en) * 2005-11-07 2007-05-17 Walter Robert Bishop Methods of treating cell proliferative disorders using a compressed temozolomide dosing schedule
WO2007146136A2 (en) * 2006-06-12 2007-12-21 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
CA2686848A1 (en) * 2007-05-08 2008-11-20 Schering Corporation Methods of treatment using intravenous formulations comprising temozolomide
US8180029B2 (en) 2007-06-28 2012-05-15 Voxer Ip Llc Telecommunication and multimedia management method and apparatus
EP2588104B1 (de) * 2010-07-01 2014-12-10 Merck Sharp & Dohme Corp. Positive allosterische isoindolon-m1-rezeptormodulatoren
EP4311386A4 (de) * 2021-03-19 2025-01-01 Hokuetsu Corporation Elektromagnetische wellenrauschunterdrückungsfolie und herstellungsverfahren dafür

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221729A (en) 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
ZA882717B (en) 1987-04-22 1988-10-17 Merrell Dow Pharmaceuticals Inc. 17beta-(cyclopropylamino)-androst-5-eb-3beta-ol and related compounds useful as c17-20 lyase inhibitors
US4966898A (en) 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
JPH06510982A (ja) 1991-02-27 1994-12-08 ニューヨーク ユニバーシティ 抗テストステロン化合物およびその使用方法
EP0573534B1 (de) 1991-03-01 1998-12-23 Electrostatic Technology, Inc. Pulverbeschichtungsverfahren zur herstellung von leiterplatten und ähnlichen
US5457102A (en) 1994-07-07 1995-10-10 Janssen Pharmaceutica, N.V. Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
ES2138618T3 (es) 1992-03-31 2000-01-16 Btg Int Ltd Esteroides 17-sustituidos utiles en el tratamiento del cancer.
GB9310635D0 (en) 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
EP0721943A4 (de) 1993-09-30 1996-09-04 Yamanouchi Pharma Co Ltd Azol-derivate und pharmazeutische präparate
WO1996014090A1 (en) 1994-11-07 1996-05-17 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
AU6015796A (en) 1995-06-14 1997-01-15 Yamanouchi Pharmaceutical Co., Ltd. Fused imidazole derivatives and medicinal composition thereof
CN1251577A (zh) 1997-02-21 2000-04-26 武田药品工业株式会社 稠环化合物及其生产和应用
DK1028110T3 (da) 1997-10-02 2004-07-19 Daiichi Seiyaku Co Hidtil ukendte dihydronaphthalenforbindelser og fremgangsmåde til fremstilling deraf
US6573289B1 (en) * 1998-04-23 2003-06-03 Takeda Chemical Industries, Ltd. Naphthalene derivatives, their production and use
PE20010781A1 (es) * 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion
US6518257B1 (en) * 1999-10-22 2003-02-11 Takeda Chemical Industries, Ltd. 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof
US6800778B1 (en) * 1999-10-22 2004-10-05 Takeda Chemical Industries, Ltd. Process for producing optically active naphthalene derivative and optical resolver therefor

Also Published As

Publication number Publication date
DE60144246D1 (de) 2011-04-28
US20040024039A1 (en) 2004-02-05
EP1344777B1 (de) 2011-03-16
US6960586B2 (en) 2005-11-01
AU2002214320A1 (en) 2002-05-27
EP1344777A4 (de) 2007-05-09
EP1344777A1 (de) 2003-09-17
WO2002040470A1 (en) 2002-05-23
CA2429437A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
ATE440096T1 (de) Substituierte thiazolderivate mit 3- pyridylgruppen, verfahren zu deren herstellung und deren verwendung
NZ532494A (en) Dibenzylamine compound and medicinal use thereof
DE60226912D1 (de) Chinolin- und Chianzolinderivate zur Behandlung von Tumoren
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
DE60318583D1 (de) N-äphenyl(piperidin-2-yl)methylübenzamid-derivate, verfahren zu deren herstellung und ihre therapeutische verwendung
CY1117132T1 (el) Παραγωγο θειαζολιου
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
EE200200148A (et) Kinasoliini derivaadid, nende valmistamise meetodning kasutamine
DE602004024880D1 (de) Azetidincarboxamid-derivate zur verwendung zur behandlung von cb1-rezeptor-vermittelten krankheiten
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
KR960701878A (ko) 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents)
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
WO2003082861A3 (en) Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
DE69406323D1 (de) Substituierte Aminsäure Derivate verwendbar für die Behandlung von Arteriosclerosis
ATE178056T1 (de) Substituierte tertiäre amine und deren salze
DK1847534T3 (da) Thiadiazolin-derivater til behandling af kræft
DE60144246D1 (de) Imidazolderivate, verfahren zu deren herstellung und deren verwendung
DE60027034D1 (de) 1-substituierte-phenyl-1-(1h-imidazol-4-yl)alkohole, verfahren zu deren herstellung sowie deren verwendung
DE3867899D1 (de) Verfahren zur herstellung von 4-amino-androstendion-derivaten.
ATE504572T1 (de) Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
DE60000978D1 (de) 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
DE69725167D1 (de) N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties